Clinical Trial Update: TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS) [Phase 3]

View source ↗

Summary

Phase 3 trial of Tenecteplase for Central Retinal Artery Occlusion has completed. No efficacy or safety results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Artery Occlusion

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: Oslo University Hospital | Conditions: Central Retinal Artery Occlusion | Phase 3 | Status: COMPLETED